Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Cash from Financing Activities (2016 - 2025)

CV Sciences (CVSI) has disclosed Cash from Financing Activities for 14 consecutive years, with $258000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 177.01% to $258000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $337000.0 through Dec 2025, up 953.12% year-over-year, with the annual reading at $337000.0 for FY2025, 953.12% up from the prior year.
  • Cash from Financing Activities hit $258000.0 in Q4 2025 for CV Sciences, up from -$234000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $2.9 million in Q1 2021 to a low of -$872000.0 in Q1 2023.
  • Historically, Cash from Financing Activities has averaged $223450.0 across 5 years, with a median of -$42000.0 in 2023.
  • Biggest five-year swings in Cash from Financing Activities: soared 8800.0% in 2021 and later crashed 498.21% in 2024.
  • Year by year, Cash from Financing Activities stood at $879000.0 in 2021, then plummeted by 183.96% to -$738000.0 in 2022, then surged by 92.41% to -$56000.0 in 2023, then plummeted by 498.21% to -$335000.0 in 2024, then soared by 177.01% to $258000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for CVSI at $258000.0 in Q4 2025, -$234000.0 in Q3 2025, and -$167000.0 in Q2 2025.